Xu Gang, Qi Furong, Li Hanjie, Yang Qianting, Wang Haiyan, Wang Xin, Liu Xiaoju, Zhao Juanjuan, Liao Xuejiao, Liu Yang, Liu Lei, Zhang Shuye, Zhang Zheng
Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518112 China.
CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong 518055 China.
Cell Discov. 2020 Oct 20;6:73. doi: 10.1038/s41421-020-00225-2. eCollection 2020.
Understanding the mechanism that leads to immune dysfunction in severe coronavirus disease 2019 (COVID-19) is crucial for the development of effective treatment. Here, using single-cell RNA sequencing, we characterized the peripheral blood mononuclear cells (PBMCs) from uninfected controls and COVID-19 patients and cells in paired broncho-alveolar lavage fluid (BALF). We found a close association of decreased dendritic cells (DCs) and increased monocytes resembling myeloid-derived suppressor cells (MDSCs), which correlated with lymphopenia and inflammation in the blood of severe COVID-19 patients. Those MDSC-like monocytes were immune-paralyzed. In contrast, monocyte-macrophages in BALFs of COVID-19 patients produced massive amounts of cytokines and chemokines, but secreted little interferons. The frequencies of peripheral T cells and NK cells were significantly decreased in severe COVID-19 patients, especially for innate-like T and various CD8 T cell subsets, compared to healthy controls. In contrast, the proportions of various activated CD4 T cell subsets among the T cell compartment, including Th1, Th2, and Th17-like cells were increased and more clonally expanded in severe COVID-19 patients. Patients' peripheral T cells showed no sign of exhaustion or augmented cell death, whereas T cells in BALFs produced higher levels of , , , , etc. Paired TCR tracking indicated abundant recruitment of peripheral T cells to the severe patients' lung. Together, this study comprehensively depicts how the immune cell landscape is perturbed in severe COVID-19.
了解导致重症2019冠状病毒病(COVID-19)免疫功能障碍的机制对于开发有效治疗方法至关重要。在此,我们使用单细胞RNA测序对未感染对照和COVID-19患者的外周血单核细胞(PBMC)以及配对支气管肺泡灌洗液(BALF)中的细胞进行了表征。我们发现树突状细胞(DC)减少与类似髓系来源抑制细胞(MDSC)的单核细胞增加密切相关,这与重症COVID-19患者血液中的淋巴细胞减少和炎症相关。那些类似MDSC的单核细胞免疫麻痹。相比之下,COVID-19患者BALF中的单核细胞-巨噬细胞产生大量细胞因子和趋化因子,但分泌很少的干扰素。与健康对照相比,重症COVID-19患者外周T细胞和NK细胞的频率显著降低,尤其是天然样T细胞和各种CD8 T细胞亚群。相反,在重症COVID-19患者中,T细胞区室中各种活化CD4 T细胞亚群的比例增加,包括Th1、Th2和Th17样细胞,并且克隆性扩增更多。患者外周T细胞没有耗竭或细胞死亡增加的迹象,而BALF中的T细胞产生更高水平的 、 、 、 等。配对TCR追踪表明外周T细胞大量募集到重症患者的肺部。总之,这项研究全面描绘了重症COVID-19中免疫细胞格局是如何受到干扰的。